Arega Pharma
ActiveSummary
Arega Pharma has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €9.8m and a net result of €6.4m. Equity is growing by ~55.3% per year across the filed fiscal years. Its solvency ranks better than 20% of 5048 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability79▲+5
Solvency43▼-8
Growth66▲+3
Track record100
Bankruptcy probability, 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €500,000 at 30 days acceptable
Liquidity tight (current ratio 1.23 against 1.32 in 2024; short-term debt: 80.2% and cash: 0% of total assets), and 81.9% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
18.1%
Return on assets
11.7%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 5048 sector peers (2025).
NBB · sector comparisonPosition among 5048 sector peers
Solvency
better than 20%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
18 d early
2024
1 d early
2023
13 d late
2022
78 d late
2021
67 d late
2020
24 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 19 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 14 August (4 of the last 5 filed years within 53 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
Turnover
€63.4m▲ 13.5%
2024 · €55.8m
EBIT margin
12.6%▲ 2.4pp
2024 · 10.2%
Net result
€6.4m▲ 57.6%
2024 · €4.0m
Working capital
€10.1m▲ 2.0%
2024 · €9.9m
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Turnover€44.6m▼ 20.3%€49.1m▲ 10.0%€51.2m▲ 4.2%€55.8m▲ 9.2%€63.4m▲ 13.5%
Operating result€2.8m▲ 68.9%€2.5m▼ 12.8%€3.5m▲ 42.6%€5.7m▲ 61.8%€8.0m▲ 40.0%
Net result€1.9mabove the sector's middle half▲ 112%€1.7mabove the sector's middle half▼ 8.1%€2.4mabove the sector's middle half▲ 41.3%€4.0mabove the sector's middle half▲ 65.1%€6.4mabove the sector's middle half▲ 57.6%
EBIT margin6.3%▲ 3.3pp5.0%▼ 1.3pp6.9%▲ 1.9pp10.2%▲ 3.3pp12.6%▲ 2.4pp
Equity€3.0mwithin the sector's middle half▲ 173%€4.7mabove the sector's middle half▲ 58.3%€7.1mabove the sector's middle half▲ 52.0%€11.2mabove the sector's middle half▲ 56.5%€9.8mabove the sector's middle half▼ 12.2%
Total assets€17.1mabove the sector's middle half▼ 6.2%€20.6mabove the sector's middle half▲ 20.3%€29.4mabove the sector's middle half▲ 42.7%€43.0mabove the sector's middle half▲ 46.5%€54.2mabove the sector's middle half▲ 25.8%
Debt€14.1m▼ 17.6%€15.2m▲ 7.9%€21.6m▲ 41.6%€31.3m▲ 45.1%€43.5m▲ 39.1%
Working capital€1.9mwithin the sector's middle half▲ 112%€4.2mabove the sector's middle half▲ 125%€6.5mabove the sector's middle half▲ 54.6%€9.9mabove the sector's middle half▲ 52.6%€10.1mabove the sector's middle half▲ 2.0%
Solvency17.3%below the sector's middle half▲ 11.4pp22.8%within the sector's middle half▲ 5.5pp24.3%within the sector's middle half▲ 1.5pp25.9%within the sector's middle half▲ 1.7pp18.1%below the sector's middle half▼ 7.8pp
Current ratio1.13below the sector's middle half▲ 0.081.28within the sector's middle half▲ 0.141.30within the sector's middle half▲ 0.031.32within the sector's middle half▲ 0.021.23within the sector's middle half▼ 0.08
Return on assets (ROA)11.0%above the sector's middle half▲ 6.1pp8.4%within the sector's middle half▼ 2.6pp8.3%within the sector's middle half▼ 0.1pp9.4%above the sector's middle half▲ 1.1pp11.7%above the sector's middle half▲ 2.4pp
Staff (FTE)50.5above the sector's middle half▲ 7.2%52.7above the sector's middle half▲ 4.4%54.8above the sector's middle half▲ 4.0%52.7above the sector's middle half▼ 3.8%53.3above the sector's middle half▲ 1.1%
above
within
below
the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 40% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €54.2m
Fixed assets
€621,969 ▼ 66.4%
Current assets
€53.5m ▲ 30.0%
Equity and liabilities €54.2m
Equity
€9.8m ▼ 12.2%
Provisions
€840,971 ▲ 40.9%
Debt
€43.5m ▲ 39.1%
Debt's share of the balance-sheet total rises from 72.7% to 80.4%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€8.1m▲
2024 · €5.8m
Cash flow
€6.5m▲
2024 · €4.2m
Quick ratio
0.74▲
2024 · 0.71
Debt to equity
4.44▲
2024 · 2.80
ROE
64.8%▲
2024 · 36.1%
Interest coverage
67.44▲
2024 · 56.88
Debt ≤ 1 year
€43.4m▲
2024 · €31.3m
Income taxes
€1.5m▼
2024 · €1.5m
Staff costs
€7.0m▼
2024 · €7.2m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 684 companies that looked in July 2024 the way this one looks now, 0.3% went bankrupt within 24 months and 97% are still going.
- Medium-sized
- solvency 10 to 30%
- a profit of 5% of the balance sheet or more
- without age
0.3%
went bankrupt
2.2%
stopped otherwise
97%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a higher bankruptcy probability: 0.8% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 684 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Operating income70/76A | €44.8m | €49.3m | €51.6m | €56.3m | €68.0m | ▲ 20.8% |
| Turnover70 | €44.6m | €49.1m | €51.2m | €55.8m | €63.4m | ▲ 13.5% |
| Other operating income74 | €175,408 | €158,876 | €470,834 | €438,143 | €285,287 | ▼ 34.9% |
| Non-recurring operating income76A | - | - | - | - | €4.3m | - |
| Operating charges60/66A | €42.0m | €46.8m | €48.1m | €50.6m | €60.0m | ▲ 18.6% |
| Goods for resale, raw materials and consumables60 | €20.0m | €22.5m | €24.0m | €26.6m | €34.3m | ▲ 29.0% |
| Purchases600/8 | €19.1m | €22.7m | €25.2m | €25.9m | €35.8m | ▲ 38.5% |
| Change in stocks: decrease (increase)609 | €953,326 | -€144,961 | -€1.3m | €692,552 | -€1.6m | ▼ 326% |
| Services and other goods61 | €11.8m | €12.9m | €14.0m | €12.3m | €13.8m | ▲ 12.4% |
| Remuneration, social security and pensions62 | €5.4m | €6.5m | €7.4m | €7.2m | €7.0m | ▼ 3.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €127,496 | €91,687 | €50,569 | €122,265 | €159,914 | ▲ 30.8% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | -€132,867 | €384,507 | - | -€611,657 | €654,230 | ▲ 207% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | €19,096 | €858,354 | €23,971 | -€100,000 | €244,000 | ▲ 344% |
| Other operating charges640/8 | €4.8m | €3.5m | €2.7m | €5.1m | €3.9m | ▼ 23.1% |
| Operating profit (loss)9901 | €2.8m | €2.5m | €3.5m | €5.7m | €8.0m | ▲ 40.0% |
| Financial income75/76B | €10,474 | €383 | €953 | €2 | €1,621 | ▲ 80,967% |
| Recurring financial income75 | €10,474 | €383 | €953 | €2 | €1,621 | ▲ 80,967% |
| Other financial income752/9 | €10,474 | €383 | €953 | €2 | €1,621 | ▲ 80,967% |
| Financial charges65/66B | €187,713 | €134,655 | €107,507 | €113,446 | €121,932 | ▲ 7.5% |
| Recurring financial charges65 | €187,713 | €134,655 | €107,507 | €113,446 | €121,932 | ▲ 7.5% |
| Debt charges650 | €143,637 | €104,227 | €104,026 | €102,047 | €120,362 | ▲ 17.9% |
| Other financial charges652/9 | €44,076 | €30,428 | €3,481 | €11,399 | €1,570 | ▼ 86.2% |
| Profit (loss) for the period before taxes9903 | €2.6m | €2.3m | €3.4m | €5.6m | €7.8m | ▲ 40.7% |
| Income taxes67/77 | €766,605 | €600,937 | €965,155 | €1.5m | €1.5m | ▼ 3.4% |
| Taxes670/3 | €766,605 | €663,365 | €965,155 | €1.5m | €1.5m | ▼ 3.4% |
| Tax adjustments and reversals of tax provisions77 | - | €62,428 | - | - | - | - |
| Profit (loss) for the period9904 | €1.9m | €1.7m | €2.4m | €4.0m | €6.4m | ▲ 57.6% |
| Profit (loss) for the period to be appropriated9905 | €1.9m | €1.7m | €2.4m | €4.0m | €6.4m | ▲ 57.6% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €17.1m | €20.6m | €29.4m | €43.0m | €54.2m | ▲ 25.8% |
| Fixed assets21/28 | €1.2m | €1.2m | €1.3m | €1.9m | €621,969 | ▼ 66.4% |
| Intangible fixed assets21 | €30,304 | €3,814 | €73,314 | €132,130 | €89,664 | ▼ 32.1% |
| Tangible fixed assets22/27 | €161,486 | €119,258 | €80,049 | €327,750 | €519,765 | ▲ 58.6% |
| Plant, machinery and equipment23 | €13,164 | €8,896 | €3,752 | - | €3,283 | - |
| Furniture and vehicles24 | €93,487 | €62,837 | €36,084 | €165,642 | €355,376 | ▲ 115% |
| Other tangible fixed assets26 | €54,835 | €47,525 | €40,213 | - | €161,106 | - |
| Assets under construction and advance payments27 | - | - | - | €162,108 | €0 | ▼ 100% |
| Financial fixed assets28 | €1.0m | €1.0m | €1.2m | €1.4m | €12,540 | ▼ 99.1% |
| Affiliated companies280/1 | €996,889 | €1.0m | €1.2m | €1.4m | €12,540 | ▼ 99.1% |
| Amounts receivable281 | €996,889 | €1.0m | €1.2m | €1.4m | €12,540 | ▼ 99.1% |
| Other financial fixed assets284/8 | €14,305 | €14,423 | €14,423 | €14,423 | €0 | ▼ 100% |
| Amounts receivable and cash guarantees285/8 | €14,305 | €14,423 | €14,423 | €14,423 | €0 | ▼ 100% |
| Current assets29/58 | €15.9m | €19.4m | €28.0m | €41.2m | €53.5m | ▲ 30.0% |
| Stocks and contracts in progress3 | €9.5m | €8.9m | €10.2m | €19.1m | €21.5m | ▲ 12.9% |
| Stocks30/36 | €9.5m | €8.9m | €10.2m | €19.1m | €21.5m | ▲ 12.9% |
| Goods purchased for resale34 | €9.5m | €8.9m | €10.2m | €19.1m | €21.5m | ▲ 12.9% |
| Amounts receivable within one year40/41 | €4.6m | €10.4m | €17.8m | €22.1m | €31.9m | ▲ 44.7% |
| Trade receivables40 | €4.6m | €5.7m | €5.2m | €8.8m | €11.7m | ▲ 33.1% |
| Other amounts receivable41 | - | €4.7m | €12.6m | €13.3m | €20.2m | ▲ 52.4% |
| Cash at bank and in hand54/58 | €1.7m | - | - | - | €5,588 | - |
| Deferred charges and accrued income490/1 | €43,788 | €88,654 | €11,493 | €68,253 | €90,216 | ▲ 32.2% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €17.1m | €20.6m | €29.4m | €43.0m | €54.2m | ▲ 25.8% |
| Equity10/15 | €3.0m | €4.7m | €7.1m | €11.2m | €9.8m | ▼ 12.2% |
| Contributions10/11 | €200,000 | €200,000 | €200,000 | €200,000 | €220,000 | ▲ 10.0% |
| Capital10 | - | - | - | - | €220,000 | - |
| Issued capital100 | - | - | - | - | €220,000 | - |
| Outside capital11 | - | - | - | - | €0 | - |
| Other1109/19 | - | - | - | - | €0 | - |
| Profit (loss) carried forward14 | €2.8m | €4.5m | €6.9m | €11.0m | €9.6m | ▼ 12.6% |
| Provisions and deferred taxes16 | €47,500 | €673,000 | €696,971 | €596,971 | €840,971 | ▲ 40.9% |
| Provisions for liabilities and charges160/5 | €47,500 | €673,000 | €696,971 | €596,971 | €840,971 | ▲ 40.9% |
| Environmental obligations163 | - | - | - | - | €840,971 | - |
| Other liabilities and charges164/5 | €47,500 | €673,000 | €696,971 | €596,971 | - | - |
| Amounts payable17/49 | €14.1m | €15.2m | €21.6m | €31.3m | €43.5m | ▲ 39.1% |
| Amounts payable within one year42/48 | €14.1m | €15.2m | €21.5m | €31.3m | €43.4m | ▲ 38.8% |
| Financial debts43 | €1.9m | - | - | - | - | - |
| Credit institutions430/8 | €1.9m | - | - | - | - | - |
| Trade debts44 | €5.3m | €8.4m | €14.1m | €22.7m | €31.6m | ▲ 39.1% |
| Suppliers440/4 | €5.3m | €8.4m | €14.1m | €22.7m | €31.6m | ▲ 39.1% |
| Taxes, remuneration and social security45 | €4.9m | €6.9m | €7.4m | €8.6m | €6.8m | ▼ 20.4% |
| Taxes450/3 | €3.5m | €5.3m | €5.5m | €6.9m | €5.5m | ▼ 20.4% |
| Remuneration and social security454/9 | €1.4m | €1.6m | €1.9m | €1.7m | €1.4m | ▼ 20.3% |
| Other amounts payable47/48 | €1.9m | - | - | - | €5.0m | - |
| Accrued charges and deferred income492/3 | €55,609 | - | €8,354 | €3,223 | €91,745 | ▲ 2,747% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €1.9m | €1.7m | €2.4m | €4.0m | €6.4m | ▲ 57.6% |
| + Depreciation and write-downs630 | €127,496 | €91,687 | €50,569 | €122,265 | €159,914 | ▲ 30.8% |
| Operating cash flow (approximation) | €2.0m | €1.8m | €2.5m | €4.2m | €6.5m | ▲ 56.8% |
| Investment in fixed assets (approximation) | - | -€52,342 | -€230,389 | -€630,488 | €1.1m | ▲ 270% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
26-08
State Gazette act
Appointment: RSM Interaudit BV (statutory auditor)Permanent representative: Kevin De Gelder · Correction4 facts ▸
State Gazette act
Appointment: RSM Interaudit BV (statutory auditor)
Permanent representative: Kevin De Gelder · Correction4 facts ▸
- General meeting, 30-06-2026
- Correction, 12-08-2026
- Auditor appointment, RSM Interaudit BV (statutory auditor)
- Permanent representative, Kevin De Gelder (permanent representative)
12-08
State Gazette act
Appointments: RSM INTERAUDIT (lid van de toezichtsraad) and WOTHAN (director)Permanent representatives: Kevin De Gelder and Kelly Wijns5 facts ▸
State Gazette act
Appointments: RSM INTERAUDIT (lid van de toezichtsraad) and WOTHAN (director)
Permanent representatives: Kevin De Gelder and Kelly Wijns5 facts ▸
- General meeting, 30-06-2026
- Auditor appointment, RSM INTERAUDIT (lid van de toezichtsraad)
- Permanent representative, Kevin De Gelder (permanent representative)
- Director appointment, WOTHAN (director)
- Permanent representative, Kelly Wijns (permanent representative)
13-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial
Highest result since 2020net €6.4m ▲57.6%
Operating result €8.0m, net result €6.4m, both a record.
30-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Equity above €10mEq €11.2m ▲56.5%
5 profitable years in a row build equity to €11.2m.
13-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 13 days late
2023
31-12
Financial
Equity above €5mEq €7.1m ▲52%
4 profitable years in a row build equity to €7.1m.
17-10
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 78 days late
2022
06-10
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 67 days late
2021
31-12
Financial
Equity above €2mEq €3.0m ▲173%
2 profitable years in a row build equity to €3.0m.
07-07
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
2 of 16 acts read
About the unread acts
Of the 16 Belgian State Gazette acts we know for this company, 2 have been read. The other 14 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 director, last change in 2026
Board 1
WOTHAN
CurrentDirector · since 04-08-2026 · Private limited company (pre-2019) · perm. rep.: Kelly Wijns
Permanent representatives 1
Kelly Wijns
CurrentPermanent representative · since 04-08-2026 · for WOTHAN
Statutory auditor 1
RSM INTERAUDIT
CurrentStatutory auditor · since 30-06-2026 · perm. rep.: Kevin De Gelder
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ.
See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
14 of this company's 16 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Mechelen · 1 establishment unit since 2019
Ground area
2,242 m²
Building footprint
1,010 m²
Parcel 12403D0040/00W005, Flanders. Linked by address, not a title deed.
15
companies at this address
See who is registered here
1 establishment unit
Arega Pharma
since 20192.289.579.288
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12403D0040/00W005 | Flanders | 2,242 m² | 1 · 1,010 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Mandate history
2 people since 2026, 2 in office
- Board
- Statutory auditor
| Name | Functions and periods |
|---|---|
| WOTHAN |
|
| RSM INTERAUDIT |
|
Structure & network
Owners and holdings
1 ownerChain of control
- Arega Health
- Arega Pharma
Highest known parent: Arega Health. The sources do not say who stands above it.
Owners 1
-
100%
Holdings 0
The accounts to 31-12-2025 list no holdings, and no other source names one.
According to the 2025 annual accounts of Arega Pharma and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
1 current directorThe group is listed under Ownership & control below; here you explore it as a network.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, scroll to zoom.
Public money · subsidies and aid
Flemish government
2022 to 2025 · 5 entries · 16,474 EUR awarded · 16,474 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 7,489 EUR | 7,489 EUR |
| 2024 | 1 | 1,552 EUR | 2,631 EUR |
| 2023 | 2 | 5,993 EUR | 4,914 EUR |
| 2022 | 1 | 1,440 EUR | 1,440 EUR |
Recognitions · licences · registrations
Food safety, FASFC
1 siteMechelen2.289.579.288
Similar companies · same sector, comparable size
OLYMPUS BELGIUM
BE 0405.804.052
Puurs-Sint-Amands · Eq €9,846,027
MONO-USO
BE 0867.442.789
Waregem · Eq €9,743,526
MEDENVISION
BE 0842.505.475
Westerlo · Eq €9,897,751
Leo Pharma
BE 0404.780.604
Lier · Eq €9,934,463
FISHER SCIENTIFIC
BE 0479.291.549
Sint-Joost-ten-Node · Eq €9,516,930
Of 1,903 companies in sector 46460 we hold annual accounts for 1,126. 448 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPublic limited company
Founded08-03-2019
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
46389Wholesale of other food products
46442Wholesale trade
46450Wholesale of perfume and cosmetics
70200Business and other management consultancy
Contact
E-mail
info@arega.com
E-invoicing
Reachable via Peppol
Peppol ID
0208:0722544585
Also
9925:BE0722544585
Registered
18-11-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.